From your first inquiry to ongoing supply — LINUO's support team is here to guide, respond, and solve. Reliable service is part of every order.
Scroll Down
Before you commit, our team works with you to ensure the right product, the right spec, and the right process — every time.
We help you choose the right packaging based on your drug and filling needs.
We customize size, wall thickness, printing, siliconization, and packaging format.
We provide samples with CoA and test data for evaluation.
We provide key documents for registration and compliance.
Once your order is placed, you're never left wondering. Our team keeps you informed at every stage of production and shipment.
We confirm your specifications, quantities, and delivery schedule after order placement.
Your dedicated account contact provides regular production updates
Every outbound shipment undergoes final quality inspection.
We follow up to confirm safe arrival and address any logistics queries promptly.
We stand behind every product we ship. If an issue arises, our after-sales team responds quickly and works with you to resolve it — no delays, no runaround.
Once your order is placed, you're never left wondering. Our team keeps you informed at every stage of production and shipment.
We provide glass-drug compatibility and E&L testing under major pharmacopoeia standards.
Filling-line equipment trial worksheet
We provide dimensional and visual inspection reports to support batch quality control.
We assist with DMF-related questions, registration data, and FDA DMF reference letters.
We support on-site customer audits and remote audits through video walkthroughs and document review.
Open the 20-question supplier audit checklist
Audit readiness for RTU vial procurement
A practical public checklist for pharmaceutical manufacturers reviewing an RTU vial supplier across facility controls, sterile-barrier components, microbiological evidence, data integrity and continuity of supply.
Confirm the physical scope, environmental controls and movement of people and materials used for the RTU vial process.
Evidence to review: Current site scope, process flow, organization responsibility matrix and approved process map.
Evidence to review: Approved cleanroom zoning, qualification status, EM plan, recent trend summary and excursion procedure.
Evidence to review: Personnel and material flow diagrams, gowning qualification, line clearance and traffic-control records.
Evidence to review: SOPs, sanitation and maintenance logs, pest-control reports, inspection findings and CAPA samples.
Review the component chain and packaging interfaces that determine whether an RTU configuration can be qualified for the customer's use.
Evidence to review: Approved supplier list, qualification records, incoming inspection plan, lot release checklist and change notifications.
Evidence to review: Material specifications, supplier CoA, lot labels, packaging BOM, sealing parameters and traceability records.
Evidence to review: Controlled CAD drawings, revision history, SKU BOM, fit-check record and deviation/change-control history.
Evidence to review: Packaging validation summary, seal or integrity test method, transport and storage assessment, approved limits and release records.
Separate glass and package controls from the customer's drug-product filling and finished container-closure qualification responsibilities.
Evidence to review: SKU specification, sampling plan, inspection standard, defect classification, trend charts and batch release records.
Evidence to review: Approved test method, method suitability or validation summary, limits, laboratory records and trend review.
Evidence to review: Sterilization cycle summary, bioburden or sterility evidence, release responsibilities and customer quality agreement.
Evidence to review: Project-specific CCI protocol, filled-product validation responsibility, applicable method and approved acceptance criteria.
Verify that batch history, electronic records and quality decisions remain attributable, legible, contemporaneous, original and accurate.
Evidence to review: Representative traceability exercise, batch genealogy, labels, ERP or MES record and mock recall result.
Evidence to review: Electronic batch record example, recipe approval, parameter audit trail, equipment log and exception handling.
Evidence to review: Access matrix, audit-trail review, backup and recovery test, system validation summary and clock-control record.
Evidence to review: Redacted investigation examples, workflow approvals, CAPA effectiveness checks and change-control records.
Test whether the supply model can withstand component, equipment, quality or logistics disruption while preserving customer notification and traceability.
Evidence to review: Critical-material risk register, alternate-source qualification status, supplier audit plan and change-notification rules.
Evidence to review: Capacity review, maintenance plan, utility-contingency plan, disaster-recovery exercise and escalation contacts.
Evidence to review: Complaint and recall SOP, retained-sample register, mock recall record, response timelines and escalation log.
Evidence to review: Business-continuity plan, logistics contingency routes, customer-notification procedure and recent drill or review record.
The 20 questions and preparation points are public so procurement, quality and engineering teams can align before an audit or qualification meeting.
Original site records, customer-specific audit reports, complete batch records, validation reports and electronic audit trails are not public downloads. They are provided only after a controlled request, confidentiality review and permission check.
Use one worksheet per vial SKU, packaging revision and machine configuration. Complete the planning fields before testing, then add observations and acceptance records. This equipment worksheet is separate from glass-drug compatibility and extractables/leachables studies.
Entries stay in this browser tab and are not submitted or saved to the website. Download your record before leaving this page, then contact LINUO to agree a suitable document-transfer route. Do not enter confidential formulation data here.
Company/site, project reference, trial date and responsible engineering or QA contact.
2R / 6R / 10R or other size; exact vial code, drawing revision, body/height/flange tolerances, stopper and cap codes.
Packaging code and revision; L × W × H, pitch/count, locating datums, support/contact areas. For Nest & Tub include both drawings; for Tray use the tray-specific drawing.
Machine OEM/model, software/recipe, grippers, guides, starwheels, filling needles, stopper/cap tooling and part numbers or drawings.
Target vials/min, trial speeds, run duration, sample quantity, batch IDs, repetitions and planned changeover.
Opening/peel method, de-nesting or tray unloading, lift/grip clearance, orientation, transfer route, interventions and observed contact.
Needle alignment, fill volume/accuracy target and result, stopper feeding/placement, partial-stop height where applicable.
Partial-stop configuration, shelf/carrier interface, loading/unloading, cycle reference and final stoppering. Mark not applicable for liquid-only trials.
Cap fit, crimp settings, inspection/rejection criteria and results; separate filled-product CCI protocol reference where required.
Define limits and measurement methods for throughput, breakage, cosmetic defects, jams, interventions, fill accuracy and closure quality. Identify approvers.
Actual speed, duration and counts; observed defects/rejects, stoppages, changeover time, deviations, corrective actions and any required repeat trial.
Report/video identifiers, sample/batch and drawing revisions, OEM/engineering/QA review, decision, restrictions and follow-up owner. This worksheet is not a signed validation approval.
Beyond core supply, LINUO offers a range of specialized services to support your product development, regulatory compliance, and long-term supply strategy.
We provide stable commercial-scale supply with green manufacturing and EMS scheduling to support reliable, on-time delivery.
Our MES system tracks each batch from raw materials to finished products, linking production records, inspection data, and CoA.
We follow GMP-aligned practices and support change studies, documentation, and regulatory submissions.
Our CNAS-accredited laboratory supports compatibility testing, elemental analysis, glass particle detection, and migration studies.
Our technical team helps you select suitable glass packaging based on formulation, filling process, and performance needs.
LINUO provides sustainable supply, fast response, and technical data support for pharmaceutical R&D and consistency evaluation.
Qualification pathway | Project-specific continuity plan
A second-source strategy should reproduce an approved vial and packaging configuration through documented comparability, line trials and quality review. LINUO structures the assessment around the customer's SKU, filling process, regulatory pathway and continuity priorities.
Qualification is tied to the selected SKU and packaging configuration. A generic RTU family description is not a substitute for project evidence.
Compare the nominated RTU vial SKU, glass tubing, critical dimensions, cosmetic defect criteria, Nest or Tray interface, Tub or secondary packaging, closure interface and sterilization configuration against the approved baseline.
Review drawings, specifications, release tests, CoA content, packaging and sterilization evidence, and any differences that require risk assessment, additional testing or a regulatory filing decision.
Plan de-nesting or tray unloading, transfer, filling, partial stoppering, lyophilization where applicable, crimping and inspection trials. The customer retains responsibility for formulation compatibility, finished-product CCI and process validation.
Inventory, notification, lead-time and emergency actions are confirmed only for the agreed project scope and commercial terms.
Agree the target SKU, forecast horizon, qualification quantities, safety-stock responsibility, shelf-life constraints and release status. Stock is committed only through the project-specific commercial agreement.
Define which source, material, tooling, process, packaging or sterilization changes require notification, the evidence route and the customer review or approval responsibility in the executed quality agreement.
Confirm current production lead time, shipment route, import and consignee requirements, controlled-document transfer and escalation contacts. No fixed lead time or regional stock position is stated on this public page.
Document triggers for allocation, alternate routing, repeat qualification, deviation or CAPA review, retained-sample and batch traceability, customer communication and return to the approved supply state.
Regional boundary: Brazil remains a project-stage supply confirmation from the China factory, subject to approved specifications and qualification. Egypt is limited to the currently confirmed RTU project scope, including RTU glass vials and cartridges and specified heat-resistant glassware project items. This page does not claim local manufacturing, unrestricted market availability or pre-qualified interchangeability. A customer-specific second-source assessment is prepared through the enquiry and project form.
Project-specific agreement | QA-controlled documents
Define responsibilities, approved specifications and evidence routes before routine RTU vial supply. The project quality agreement aligns supplier controls with the customer's filling process, finished-product responsibilities and regulatory pathway.
Manufacture, inspect and release against the approved RTU vial specification and drawing revision; maintain batch traceability; and manage assessed changes, deviations and CAPA through the agreed communication route.
Typical evidence path: approved specification, inspection and release records, CoA, batch records, retained records and agreed investigation outputs.
Confirm intended use and the selected vial/closure configuration; qualify formulation and process compatibility; validate filling, stoppering, crimping and sterilized handling; and establish finished-product CCI and regulatory suitability.
Typical evidence path: user requirement, approved drawing, filling-line and closure studies, finished-product validation and market-specific regulatory assessment.
Agree the SKU, drawing revision, sampling plan, test methods, acceptance criteria and release documentation before supply. Define how disputes, additional testing and conditional decisions are escalated.
The signed agreement should identify applicable records, reviewers, retention expectations and the route for controlled document exchange.
Each release decision should be tied to the agreed product configuration and batch evidence, rather than a generic RTU vial family description.
Identify the vial SKU, closure interface, drawing and specification revisions, test methods and applicable packaging/sterilization configuration.
Define sampling location, sample quantity, inspection level and acceptance criteria for the project or supply stage.
Review inspection results, batch status and agreed release documents, including the CoA where applicable.
Link samples, records, deviations and decisions to the batch, drawing revision and controlled communication history.
Potential changes are classified and assessed for product, process, regulatory and customer impact. Notification, data review and approval requirements are then applied according to the executed agreement.
Assess source, grade, critical attributes, incoming controls and potential impact on vial performance.
Document the classification, risk assessment and required technical or regulatory evidence.
Assess tooling, forming, inspection and other equipment changes that may affect dimensions, defects or validated controls.
Define verification, comparability and any customer notification or approval route in the agreement.
Assess process chemistry, equipment, parameters, residues, particle/endotoxin controls and any relevant validation impact.
Use risk-based data and approved change records before implementation or external communication.
Assess packaging materials/configuration, sterile-barrier handling, sterilization method or parameters, transport and shelf-life implications.
Determine notification, qualification and approval requirements from classification and regulatory impact.
Contain the event, classify its significance, assess affected material and investigate the cause.
Record immediate action, disposition, responsibilities, due dates, QA review and closure.
Capture the complaint and sample information, establish batch traceability, investigate and communicate through the agreed route.
Maintain complaint evidence, findings, response, trend links and any required follow-up.
Translate confirmed root cause and risk into corrective and preventive actions with named owners and completion dates.
Verify implementation and effectiveness; include follow-up batch monitoring when agreed and justified.
Define escalation contacts, decision responsibilities and the supplier information needed to identify potentially affected batches.
Preserve the event timeline, batch scope, communications, disposition and closure evidence.
Link raw material, process, inspection, packaging and release records to the supplied batch and agreed retained samples.
Set retention, access and controlled transfer expectations in the executed quality agreement.
The following internal templates inform the quality-agreement workflow. They are not public downloads. An external copy is provided only after QA approval and project-specific review.
Structures the reason and scope of change, before/after description, risk and cross-functional assessment, actions, notification, approval, implementation check and closure.
Controlled internal reference | QA approval required before external releaseStructures deviation description and containment, classification, impact and root-cause assessment, correction/CAPA, effectiveness review, follow-up and QA closure.
Controlled internal reference | QA approval required before external release
We will reply to you within 24 hours. If for urgent case, please add WhatsApp/WeChat: +8615953131507, Or call +8618615646416 directly.
*We respect your confidentiality and all information are protected.
We will only use your information to respond to your inquiry and will never send unsolicited emails or promotional messages.
